Raloxifene 4'-D-glucuronide

CAS: 182507-22-8

Ref. 3D-MR07277

Información del producto

• Nombre: Raloxifene 4'-D-glucuronide
• Sinónimos: 4-[6-Hydroxy-3-[4-2[2-(1-piperindinyl)ethoxy]benzoyl]benzo[b]thien-2-yl]phenyl-b-D-glucopyranosiduronic acid, (4-[6-Hydroxy-3-[4-[2-(1-piperidinyl)ethoxy-D4]benzoyl]benzo[b]thien-2-yl]phenyl-D-glucopyranosiduronic acid), 4-[6-Hydroxy-3-[4-[2-(1-piperidinyl)ethoxy-d4]benzoyl]benzo[b]thien-2-yl]phenyl-b-D-glucopyranosiduronic Acid, 4-[6-Hydroxy-3-[4-[2-(1-piperidinyl)ethoxy]benzoyl]benzo[b]thien-2-yl]phenyl β-<span class="text-smallcaps">D</span>-glucopyranosiduronic acid, 4-[6-Hydroxy-3-[4-[2-(1-piperidinyl)ethoxy]benzoyl]benzo[b]thien-2-yl]phenyl-D-glucopyranosiduronicacid, 4-[6-Hydroxy-3-[4-[2-(1-piperidinyl)ethoxy]benzoyl]benzo[b]thien-2-yl]phenyl-b-D-glucopyranosiduronic Acid, Raloxifene-D4-4'-Glucuronide, β-<span class="text-smallcaps">D</span>-Glucopyranosiduronic acid, 4-[6-hydroxy-3-[4-[2-(1-piperidinyl)ethoxy]benzoyl]benzo[b]thien-2-yl]phenyl
• CAS: 182507-22-8

Descripción

Raloxifene 4'-D-glucuronide is a drug that is a prodrug of raloxifene, and it can be used to treat osteoporosis. The compound is metabolized by glucuronidation in the liver, and it has been found to have bioequivalence with the parent drug. Raloxifene 4'-D-glucuronide is marketed under the trade name Evista.

Raloxifene 4'-D-glucuronide is a prodrug of raloxifene, which can be used to treat osteoporosis. This compound has been found to have bioequivalence with the parent drug and is marketed under the trade name Evista.

• Marca: Biosynth

Propiedades químicas

• Peso molecular: 649.71 g/mol
• Fórmula: C₃₄H₃₅NO₁₀S
• Pureza: Min. 95%